<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="file:///tmp/tableDisplay.xsl"?>
<entity>
<logicalTable>
<tableAttributes>
<meta name="key" value="c3/r13/e/i/c/Eicosanoid.html_0.xml" />
<meta name="primaryKey" value="1.0 0, 0.8333333 0 1, 0.6666667 0 2, 0.5769231 1, 0.5641026 2, 0.4700855 1 2, " />
<meta name="parentHTMLDoc" value="en/articles/e/i/c/Eicosanoid.html" />
<meta name="isList" value="false" />
</tableAttributes>
<content>
<header>
<cell>
	<html><![CDATA[<th>Medicine</th>]]></html>
	<text>Medicine</text>
</cell>
<cell>
	<html><![CDATA[<th>Type</th>]]></html>
	<text>Type</text>
</cell>
<cell>
	<html><![CDATA[<th>Medical condition or use</th>]]></html>
	<text>Medical condition or use</text>
</cell>
</header>

<row>
<cell>
	<html><![CDATA[<td>Alprostadil</td>]]></html>
	<text>Alprostadil</text>
</cell>
<cell>
	<html><![CDATA[<td>PGI 1</td>]]></html>
	<text>PGI 1</text>
</cell>
<cell>
	<html><![CDATA[<td>Erectile dysfunction , maintaining a patent ductus arteriosus in the fetus</td>]]></html>
	<text>Erectile dysfunction , maintaining a patent ductus arteriosus in the fetus</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Beraprost</td>]]></html>
	<text>Beraprost</text>
</cell>
<cell>
	<html><![CDATA[<td>PGI 1 analog</td>]]></html>
	<text>PGI 1 analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Pulmonary hypertension , avoiding reperfusion injury</td>]]></html>
	<text>Pulmonary hypertension , avoiding reperfusion injury</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Bimatoprost</td>]]></html>
	<text>Bimatoprost</text>
</cell>
<cell>
	<html><![CDATA[<td>PG analog</td>]]></html>
	<text>PG analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Glaucoma , ocular hypertension</td>]]></html>
	<text>Glaucoma , ocular hypertension</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Carboprost</td>]]></html>
	<text>Carboprost</text>
</cell>
<cell>
	<html><![CDATA[<td>PG analog</td>]]></html>
	<text>PG analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Labor induction , abortifacient in early pregnancy</td>]]></html>
	<text>Labor induction , abortifacient in early pregnancy</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Dinoprostone</td>]]></html>
	<text>Dinoprostone</text>
</cell>
<cell>
	<html><![CDATA[<td>PGE 2</td>]]></html>
	<text>PGE 2</text>
</cell>
<cell>
	<html><![CDATA[<td>Labor induction</td>]]></html>
	<text>Labor induction</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Iloprost</td>]]></html>
	<text>Iloprost</text>
</cell>
<cell>
	<html><![CDATA[<td>PGI 2 analog</td>]]></html>
	<text>PGI 2 analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Pulmonary arterial hypertension</td>]]></html>
	<text>Pulmonary arterial hypertension</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Latanoprost</td>]]></html>
	<text>Latanoprost</text>
</cell>
<cell>
	<html><![CDATA[<td>PG analog</td>]]></html>
	<text>PG analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Glaucoma , ocular hypertension</td>]]></html>
	<text>Glaucoma , ocular hypertension</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Misoprostol</td>]]></html>
	<text>Misoprostol</text>
</cell>
<cell>
	<html><![CDATA[<td>PGE 1 analog</td>]]></html>
	<text>PGE 1 analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Stomach ulcers , labor induction , abortifacient</td>]]></html>
	<text>Stomach ulcers , labor induction , abortifacient</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Montelukast</td>]]></html>
	<text>Montelukast</text>
</cell>
<cell>
	<html><![CDATA[<td>LT receptor antagonist</td>]]></html>
	<text>LT receptor antagonist</text>
</cell>
<cell>
	<html><![CDATA[<td>Asthma , seasonal allergies</td>]]></html>
	<text>Asthma , seasonal allergies</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Travoprost</td>]]></html>
	<text>Travoprost</text>
</cell>
<cell>
	<html><![CDATA[<td>PG analog</td>]]></html>
	<text>PG analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Glaucoma , ocular hypertension</td>]]></html>
	<text>Glaucoma , ocular hypertension</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Treprostinil</td>]]></html>
	<text>Treprostinil</text>
</cell>
<cell>
	<html><![CDATA[<td>PGI analog</td>]]></html>
	<text>PGI analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Pulmonary hypertension</td>]]></html>
	<text>Pulmonary hypertension</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>U46619</td>]]></html>
	<text>U46619</text>
</cell>
<cell>
	<html><![CDATA[<td>Longer lived TX analog</td>]]></html>
	<text>Longer lived TX analog</text>
</cell>
<cell>
	<html><![CDATA[<td>Research only</td>]]></html>
	<text>Research only</text>
</cell>
</row>

<row>
<cell>
	<html><![CDATA[<td>Zafirlukast</td>]]></html>
	<text>Zafirlukast</text>
</cell>
<cell>
	<html><![CDATA[<td>LT receptor antagonist</td>]]></html>
	<text>LT receptor antagonist</text>
</cell>
<cell>
	<html><![CDATA[<td>Asthma</td>]]></html>
	<text>Asthma</text>
</cell>
</row>

</content>
<tableContext>
<context>
	<score>1.0</score>
	<text>Pharmacy: Eicosanoid, eicosanoid analogs and receptor agonists/antagonists used as medicines</text>
</context>
<context>
	<score>1.0</score>
	<text>Eicosanoid - Wikipedia, the free encyclopedia</text>
</context>
<context>
	<score>1.0</score>
	<text>Medicine Type Medical condition or use</text>
</context>
<context>
	<score>0.8808633</score>
	<text>Since antiquity , the cardinal signs of inflammation have been known as: calor (warmth), dolor (pain), tumor (swelling) and rubor (redness). The eicosanoids are involved with each of these signs.</text>
</context>
<context>
	<score>0.79696953</score>
	<text>Eicosanoid</text>
</context>
<context>
	<score>0.7838936</score>
	<text>[ edit ] Role in inflammation</text>
</context>
<context>
	<score>0.75252104</score>
	<text>Redness An insect&apos;s sting will trigger the classic inflammatory response. Short acting vasoconstrictors TXA 2 are released quickly after the injury. The site may momentarily turn pale. Then TXA 2 mediates the release of the vasodilators PGE 2 and LTB 4 . The blood vessels engorge and the injury reddens.</text>
</context>
<context>
	<score>0.7214693</score>
	<text>[ edit ] Nomenclature</text>
</context>
<context>
	<score>0.7214693</score>
	<text>[ edit ] Biosynthesis</text>
</context>
<context>
	<score>0.7214693</score>
	<text>[ edit ] Function and pharmacology</text>
</context>
<context>
	<score>0.7214693</score>
	<text>[ edit ] History</text>
</context>
<context>
	<score>0.7214693</score>
	<text>[ edit ] References</text>
</context>
<context>
	<score>0.7214693</score>
	<text>[ edit ] External links</text>
</context>
<context>
	<score>0.71939373</score>
	<text>Contents</text>
</context>
<context>
	<score>0.7042423</score>
	<text>Dietary -3 and GLA counter the inflammatory effects of AA&apos;s eicosanoids in three ways, along the eicosanoid pathways:</text>
</context>
<context>
	<score>0.66493565</score>
	<text>Kevin Fritsche, Fatty Acids as Modulators of the Immune Response [20]</text>
</context>
<context>
	<score>0.6442571</score>
	<text>The eicosanoids from AA generally promote inflammation. Those from EPA and from GLA ( via DGLA) are generally less inflammatory, or inactive, or even anti-inflammatory. The figure shows the -3 and -6 synthesis chains, along with the major eicosanoids from AA, EPA and DGLA.</text>
</context>
<context>
	<score>0.6057242</score>
	<text>Swelling LTB 4 makes the blood vessels more permeable. Plasma leaks out into the connective tissues, and they swell. The process also looses pro-inflammatory cytokines.</text>
</context>
<context>
	<score>0.59253305</score>
	<text>EFA sources: Essential fatty acid production and metabolism to form eicosanoids. At each step, the -3 and -6 cascades compete for the enzymes.</text>
</context>
<context>
	<score>0.5548898</score>
	<text>[ edit ] Mechanisms of -3 action</text>
</context>
<context>
	<score>0.5210392</score>
	<text>Of these, the action on eicosanoids is the best explored.</text>
</context>
<context>
	<score>0.5193732</score>
	<text>Pain The cytokines increase COX-2 activity. This elevates levels of PGE 2 , sensitizing pain neurons.</text>
</context>
<context>
	<score>0.4976947</score>
	<text>Besides the influence on eicosanoids, dietary polyunsaturated fats modulate immune response through three other molecular mechanisms. They (a) alter membrane composition and function , including the composition of lipid rafts ; (b) change cytokine biosynthesis and (c) directly activate gene transcription.</text>
</context>
<context>
	<score>0.47735867</score>
	<text>The U.S. National Institutes of Health and the National Library of Medicine state that there is &apos;A&apos; level evidence (&apos;strong scientific evidence&apos;) that increased dietary -3 improves outcomes in hypertriglyceridemia , secondary cardiovascular disease prevention and hypertension . There is &apos;B&apos; level evidence (&apos;good scientific evidence&apos;) for increased dietary -3 in primary prevention of cardiovascular disease, rheumatoid arthritis and protection from ciclosporin toxicity in organ transplant patients. They also note more preliminary evidence showing that dietary -3 can ease symptoms in several psychiatric disorders.</text>
</context>
<context>
	<score>0.46857843</score>
	<text>Heat PGE 2 is also a potent pyretic agent. Aspirin and NSAIDS drugs that block the COX pathways and stop prostanoid synthesis limit fever or the heat of localized inflammation.</text>
</context>
<context>
	<score>0.46108985</score>
	<text>In the inflammatory response, two other groups of dietary essential fatty acids form cascades that parallel and compete with the arachidonic acid cascade. EPA (20:5 -3) provides the most important competing cascade. DGLA (20:3 -6) provides a third, less prominent cascade. These two parallel cascades soften the inflammatory effects of AA and its products. Low dietary intake of these less-inflammatory essential fatty acids, especially the -3s, has been linked to several inflammation-related diseases, and perhaps some mental illnesses .</text>
</context>
</tableContext>
</logicalTable>
<headerSynset>
</headerSynset>
<htmlSnippet>
<![CDATA[
<table class="wikitable" style="margin: 1em 0 1em 1em; float: right;"><caption>Pharmacy: Eicosanoid, eicosanoid analogs and receptor agonists/antagonists used as medicines</caption><tr><th>Medicine</th><th>Type</th><th>Medical condition or use</th></tr><tr><td valign="top"><a href="../../../../articles/a/l/p/Alprostadil.html" title="Alprostadil">Alprostadil</a></td><td valign="top">PGI<sub>1</sub></td><td><a href="../../../../articles/e/r/e/Erectile_dysfunction.html" title="Erectile dysfunction">Erectile dysfunction</a>, maintaining a<br /><a href="../../../../articles/p/a/t/Patent_ductus_arteriosus.html" title="Patent ductus arteriosus">patent ductus arteriosus</a> in the <a href="../../../../articles/f/e/t/Fetus.html" title="Fetus">fetus</a></td></tr><tr><td valign="top"><a href="../../../../articles/b/e/r/Beraprost.html" title="Beraprost">Beraprost</a></td><td valign="top">PGI<sub>1</sub> analog</td><td><a href="../../../../articles/p/u/l/Pulmonary_hypertension.html" title="Pulmonary hypertension">Pulmonary hypertension</a>, avoiding<br /><a href="../../../../articles/r/e/p/Reperfusion_injury.html" title="Reperfusion injury">reperfusion injury</a></td></tr><tr><td><a href="../../../../articles/b/i/m/Bimatoprost.html" title="Bimatoprost">Bimatoprost</a></td><td>PG analog</td><td><a href="../../../../articles/g/l/a/Glaucoma.html" title="Glaucoma">Glaucoma</a>, ocular <a href="../../../../articles/h/y/p/Hypertension.html" title="Hypertension">hypertension</a></td></tr><tr><td valign="top"><a href="../../../../articles/c/a/r/Carboprost.html" title="Carboprost">Carboprost</a></td><td valign="top">PG analog</td><td><a href="../../../../articles/i/n/d/Induction_%28birth%29.html" title="Induction (birth)">Labor induction</a>, <a href="../../../../articles/a/b/o/Abortifacient.html" title="Abortifacient">abortifacient</a><br />in early pregnancy</td></tr><tr><td><a href="../../../../articles/d/i/n/Dinoprostone.html" title="Dinoprostone">Dinoprostone</a></td><td>PGE<sub>2</sub></td><td><a href="../../../../articles/i/n/d/Induction_%28birth%29.html" title="Induction (birth)">Labor induction</a></td></tr><tr><td><a href="../../../../articles/i/l/o/Iloprost.html" title="Iloprost">Iloprost</a></td><td>PGI<sub>2</sub> analog</td><td><a href="../../../../articles/p/u/l/Pulmonary_hypertension.html" title="Pulmonary hypertension">Pulmonary arterial hypertension</a></td></tr><tr><td><a href="../../../../articles/l/a/t/Latanoprost.html" title="Latanoprost">Latanoprost</a></td><td>PG analog</td><td><a href="../../../../articles/g/l/a/Glaucoma.html" title="Glaucoma">Glaucoma</a>, ocular <a href="../../../../articles/h/y/p/Hypertension.html" title="Hypertension">hypertension</a></td></tr><tr><td valign="top"><a href="../../../../articles/m/i/s/Misoprostol.html" title="Misoprostol">Misoprostol</a></td><td valign="top">PGE<sub>1</sub> analog</td><td><a href="../../../../articles/p/e/p/Peptic_ulcer.html" title="Peptic ulcer">Stomach ulcers</a>, <a href="../../../../articles/i/n/d/Induction_%28birth%29.html" title="Induction (birth)">labor induction</a>,<br /><a href="../../../../articles/a/b/o/Abortifacient.html" title="Abortifacient">abortifacient</a></td></tr><tr><td valign="top"><a href="../../../../articles/m/o/n/Montelukast.html" title="Montelukast">Montelukast</a></td><td>LT <a href="../../../../articles/r/e/c/Receptor_antagonist.html" title="Receptor antagonist">receptor<br />antagonist</a></td><td valign="top"><a href="../../../../articles/a/s/t/Asthma.html" title="Asthma">Asthma</a>, seasonal <a href="../../../../articles/a/l/l/Allergy.html" title="Allergy">allergies</a></td></tr><tr><td><a href="../../../../articles/t/r/a/Travoprost.html" title="Travoprost">Travoprost</a></td><td>PG analog</td><td><a href="../../../../articles/g/l/a/Glaucoma.html" title="Glaucoma">Glaucoma</a>, ocular <a href="../../../../articles/h/y/p/Hypertension.html" title="Hypertension">hypertension</a></td></tr><tr><td><a href="../../../../articles/t/r/e/Treprostinil.html" title="Treprostinil">Treprostinil</a></td><td>PGI analog</td><td><a href="../../../../articles/p/u/l/Pulmonary_hypertension.html" title="Pulmonary hypertension">Pulmonary hypertension</a></td></tr><tr><td valign="top">U46619</td><td>Longer lived<br />TX analog</td><td valign="top">Research only</td></tr><tr><td valign="top"><a href="../../../../articles/z/a/f/Zafirlukast.html" title="Zafirlukast">Zafirlukast</a></td><td>LT <a href="../../../../articles/r/e/c/Receptor_antagonist.html" title="Receptor antagonist">receptor<br />antagonist</a></td><td valign="top"><a href="../../../../articles/a/s/t/Asthma.html" title="Asthma">Asthma</a></td></tr></table>]]>
</htmlSnippet>
</entity>